GIDRP88 Activators are a specialized set of chemical compounds that enhance the activity of GIDRP88 by modulating various signal transduction pathways within the cell. Forskolin, for instance, by increasing intracellular cAMP levels, indirectly activates GIDRP88 through the activation of PKA, which is known to phosphorylate various proteins including GIDRP88. Similarly, db-cAMP and 8-Bromo-cAMP, both stable analogs of cAMP, enhance GIDRP88 activity by activating PKA, which in turn could lead to the phosphorylation of GIDRP88. On a different signaling axis, PMA, as a PKC activator, and Sphingosine-1-phosphate, through G-protein coupled receptor signaling, lead to downstream kinase activation that may result in enhanced phosphorylation and activity of GIDRP88. LY294002, by inhibiting PI3K, may alter the balance of kinase activities in the cell, potentially leading to the activation of kinases that positively regulate GIDRP88.
In addition to the above mechanisms, the activity of GIDRP88 is also influenced by compounds that modulate calcium signaling and protein phosphorylation states. Ionomycin and A23187, both calcium ionophores, raise intracellular calcium levels, which could lead to the activation of calcium-dependent kinases that phosphorylate GIDRP88, thus indirectly enhancing its functional activity. Okadaic acid and Calyculin A, as inhibitors of protein phosphatases, prolong the phosphorylated state of proteins, which could include the phosphorylation enhancement of GIDRP88. EGCG, by inhibiting several protein kinases, might shift signaling pathways to favor the activation of those kinases that are responsible for GIDRP88 activation. Anisomycin, though primarily a protein synthesis inhibitor, activates stress-activated protein kinases, which could also lead to the phosphorylation and subsequent activation of GIDRP88, integrating stress response pathways with the enhancement of GIDRP88 function. Collectively, these activators employ a diverse range of molecular mechanisms to ensure the potentiation of GIDRP88's activity within the cell, reflecting the intricate web of intracellular signaling and its regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin acts by elevating cyclic AMP (cAMP) levels, which can lead to the activation of protein kinase A (PKA). PKA can phosphorylate GIDRP88, enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in many signal transduction pathways. PKC activation can result in the phosphorylation and subsequent activation of GIDRP88. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin functions as a calcium ionophore, increasing intracellular calcium levels and potentially activating calcium-dependent protein kinases that could phosphorylate and activate GIDRP88. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
db-cAMP is a cell-permeable analog of cAMP that resists degradation and thus potently raises intracellular cAMP levels, which can activate PKA and enhance GIDRP88 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is known to inhibit several protein kinases, potentially altering signaling pathways and indirectly leading to the activation of kinases that phosphorylate GIDRP88, thus enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, which can lead to downstream kinase activation and may result in the phosphorylation and activation of GIDRP88. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, which can shift the balance of intracellular signaling pathways, possibly leading to the activation of alternative pathways that enhance GIDRP88 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins, which could include GIDRP88, thus enhancing its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs), which could lead to the activation of GIDRP88 through stress response pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore like ionomycin, which can increase intracellular calcium levels, activating calcium-dependent kinases that may phosphorylate and enhance GIDRP88 activity. |